Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Completion of genetic testing is increasingly important for the complex care of patients with suspected hereditary breast and ovarian cancers (HBOC) and their at-risk family members. Identification of individuals with pathogenic variants has implications for targeted treatment recommendations, risk...

Descripción completa

Detalles Bibliográficos
Autores principales: McAlarnen, Lindsey, Stearns, Kristen, Uyar, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814235/
https://www.ncbi.nlm.nih.gov/pubmed/33488111
http://dx.doi.org/10.2147/TACG.S245021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814235/
https://www.ncbi.nlm.nih.gov/pubmed/33488111
http://dx.doi.org/10.2147/TACG.S245021

Ejemplares similares